Your browser doesn't support javascript.
loading
Interception of host fatty acid metabolism by mycobacteria under hypoxia to suppress anti-TB immunity.
Yang, Hua; Wang, Fei; Guo, Xinya; Liu, Feng; Liu, Zhonghua; Wu, Xiangyang; Zhao, Mengmeng; Ma, Mingtong; Liu, Haipeng; Qin, Lianhua; Wang, Lin; Tang, Tianqi; Sha, Wei; Wang, Yang; Chen, Jianxia; Huang, Xiaochen; Wang, Jie; Peng, Cheng; Zheng, Ruijuan; Tang, Fen; Zhang, Lu; Wu, Chunyan; Oehlers, Stefan H; Song, Zhigang; She, Jialei; Feng, Hua; Xie, Xunwei; Ge, Baoxue.
Afiliação
  • Yang H; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang F; Department of Microbiology and Immunology, Tongji University School of Medicine, Shanghai, China.
  • Guo X; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Liu F; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Liu Z; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wu X; Department of Microbiology and Immunology, Tongji University School of Medicine, Shanghai, China.
  • Zhao M; Department of Microbiology and Immunology, Tongji University School of Medicine, Shanghai, China.
  • Ma M; Department of Microbiology and Immunology, Tongji University School of Medicine, Shanghai, China.
  • Liu H; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Qin L; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang L; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Tang T; Department of Microbiology and Immunology, Tongji University School of Medicine, Shanghai, China.
  • Sha W; Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang Y; Department of Microbiology and Immunology, Tongji University School of Medicine, Shanghai, China.
  • Chen J; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Huang X; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang J; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Peng C; Department of Microbiology and Immunology, Tongji University School of Medicine, Shanghai, China.
  • Zheng R; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Tang F; Department of Microbiology and Immunology, Tongji University School of Medicine, Shanghai, China.
  • Zhang L; State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, China.
  • Wu C; Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Oehlers SH; Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia.
  • Song Z; Eastern China Center for Pathogen Discovery and Research, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • She J; Eastern China Center for Pathogen Discovery and Research, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Feng H; Omics Core of Bio-Med Big Data Center, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Xie X; China Zebrafish Resource Center, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Ge B; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. gebaoxue@sibs.ac.cn.
Cell Discov ; 7(1): 90, 2021 Oct 05.
Article em En | MEDLINE | ID: mdl-34608123
ABSTRACT
Pathogenic mycobacteria induce the formation of hypoxic granulomas during latent tuberculosis (TB) infection, in which the immune system contains, but fails to eliminate the mycobacteria. Fatty acid metabolism-related genes are relatively overrepresented in the mycobacterial genome and mycobacteria favor host-derived fatty acids as nutrient sources. However, whether and how mycobacteria modulate host fatty acid metabolism to drive granuloma progression remains unknown. Here, we report that mycobacteria under hypoxia markedly secrete the protein Rv0859/MMAR_4677 (Fatty-acid degradation A, FadA), which is also enriched in tuberculous granulomas. FadA acts as an acetyltransferase that converts host acetyl-CoA to acetoacetyl-CoA. The reduced acetyl-CoA level suppresses H3K9Ac-mediated expression of the host proinflammatory cytokine Il6, thus promoting granuloma progression. Moreover, supplementation of acetate increases the level of acetyl-CoA and inhibits the formation of granulomas. Our findings suggest an unexpected mechanism of a hypoxia-induced mycobacterial protein suppressing host immunity via modulation of host fatty acid metabolism and raise the possibility of a novel therapeutic strategy for TB infection.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article